Surevest’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.55M Sell
31,546
-853
-3% -$76.7K 0.69% 61
2022
Q2
$2.91M Buy
32,399
+2,059
+7% +$209K 0.76% 55
2022
Q1
$3.37M Sell
30,340
-4,378
-13% -$463K 0.81% 50
2021
Q4
$3.59M Sell
34,718
-1,747
-5% -$202K 0.85% 57
2021
Q3
$4.57M Buy
36,465
+1,915
+6% +$248K 1.15% 40
2021
Q2
$4.29M Sell
34,550
-1,017
-3% -$128K 1.12% 49
2021
Q1
$4.2M Buy
35,567
+1,253
+4% +$147K 1.27% 48
2020
Q4
$4.02M Buy
34,314
+1,084
+3% +$119K 1.34% 36
2020
Q3
$3.45M Buy
33,230
+2,834
+9% +$285K 1.36% 34
2020
Q2
$2.79M Buy
30,396
+4,065
+15% +$390K 1.23% 50
2020
Q1
$2.38M Buy
26,331
+7,191
+38% +$765K 1.29% 40
2019
Q4
$2.17M Buy
19,140
+4,389
+30% +$482K 0.93% 41
2019
Q3
$1.6M Buy
14,751
+1,609
+12% +$168K 0.79% 52
2019
Q2
$1.28M Buy
13,142
+6,224
+90% +$568K 0.66% 62
2019
Q1
$630K Buy
6,918
+3,833
+124% +$343K 0.39% 84
2018
Q4
$281K Buy
+3,085
New +$288K 0.22% 93

Other funds holding MDT

Surevest's MDT Position: Q3 2022 in Review

Surevest reduced its Medtronic (MDT) stake by 2.6% in Q3 2022, selling an estimated $76.7K and leaving 31,546 shares worth $2.55M. The position accounts for 0.69% of the portfolio, ranked #61.

Surevest first reported a position in MDT in Q4 2018 and has held it in 16 quarters since. The position peaked at $4.57M in Q3 2021. 1,930 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Surevest held 31,546 shares of Medtronic worth $2.55M as of Q3 2022.
  • Surevest sold 853 Medtronic shares in Q3 2022, an estimated $76.7K.
  • Medtronic made up 0.69% of Surevest's portfolio in Q3 2022, its #61 holding.
  • Surevest first reported a position in Medtronic in Q4 2018 and has held it in 16 quarters since.
  • Surevest's Medtronic position peaked at $4.57M in Q3 2021.
  • 1,930 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.